Population Pharmacokinetics of Pyrazinamide in Patients With Tuberculosis

Antimicrobial Agents and Chemotherapy- United States

doi 10.1128/aac.02625-16

Full Text

Abstract

Available in

Categories

Infectious Diseases

Date

March 13, 2017

Authors

Abdullah Alsultan

Kelly E. Dooley

William Whitworth

William R. Mac Kenzie

Charles A. Peloquin

Publisher

American Society for Microbiology

Related search

Good Tolerance of Pyrazinamide in Children With Pulmonary Tuberculosis.

Archives of Disease in Childhood

English

Susceptibility Testing of Mycobacterium Tuberculosis to Pyrazinamide

Journal of Medical Microbiology

English

Population Pharmacokinetics of Anidulafungin in Critically Ill Patients

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients

Clinical Drug Investigation

English

Pyrazinamide: An Essential Drug in the Tuberculosis Treatment

Revista Virtual de Quimica

English

Population Pharmacokinetics of Rifampin in Pregnant Women With Tuberculosis and HIV Coinfection in Soweto, South Africa

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium Tuberculosis Pyrazinamide Resistance

Journal of Clinical Microbiology

English

Population Pharmacokinetics of Brodalumab in Patients With Moderate to Severe Plaque Psoriasis

Basic and Clinical Pharmacology and Toxicology

English

Population Pharmacokinetics of Intramuscular Droperidol in Acutely Agitated Patients

British Journal of Clinical Pharmacology

English